Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages - PubMed (original) (raw)

Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages

A Roggenkamp et al. Med Microbiol Immunol. 1999 Dec.

Abstract

Phagocytosis resistance even in the presence of opsonizing antibodies is a key feature of pathogenic Yersinia spp. Nevertheless, antibodies against the secreted V antigen and the outer membrane protein YadA are known to mediate protection against Y. enterocolitica serotype 08 in a mouse model with intravenous infection. To investigate the impact of anti-V antigen serum on the interaction of Y. enterocolitica and phagocytic cells, gentamicin kill assays and immunofluorescence staining were performed. In contrast to anti-YadA, the presence of V antigen-specific antibodies resulted in an increased uptake of yersiniae by macrophages. The inhibition of phagocytosis by cytochalasin D suppressed the anti-V antigen-mediated uptake. The uptake-promoting effect of anti-V antigen was more distinct for macrophages than for polymorphonuclear leukocytes. The findings of the passive immunization experiments using an orogastric infection model were in agreement with those of cell-culture experiments. In the first 3 days of infection both antisera exhibit no protective effect on the multiplication of the bacteria in the Peyer's patches. Only mice passively immunized with anti-V antigen survived lethal oral infections with Y. enterocolitica serotype 08. Taken together, the results support the assumption that V antigen might be part of the translocation apparatus and that anti-V antigen inhibits the Yop translocation. In addition, antisera against in-frame-deleted recombinant V antigen were generated. Protection experiments using these antisera suggested that the type-specific region (amino acids 225-232) of the V antigen might not be a protective epitope.

PubMed Disclaimer

Cited by

Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
Cowan C, Philipovskiy AV, Wulff-Strobel CR, Ye Z, Straley SC. Cowan C, et al. Infect Immun. 2005 Sep;73(9):6127-37. doi: 10.1128/IAI.73.9.6127-6137.2005. Infect Immun. 2005. PMID: 16113334 Free PMC article.
Amino acid and structural variability of Yersinia pestis LcrV protein.
Anisimov AP, Dentovskaya SV, Panfertsev EA, Svetoch TE, Kopylov PKh, Segelke BW, Zemla A, Telepnev MV, Motin VL. Anisimov AP, et al. Infect Genet Evol. 2010 Jan;10(1):137-45. doi: 10.1016/j.meegid.2009.10.003. Epub 2009 Oct 14. Infect Genet Evol. 2010. PMID: 19835996 Free PMC article.
Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
Philipovskiy AV, Cowan C, Wulff-Strobel CR, Burnett SH, Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. Philipovskiy AV, et al. Infect Immun. 2005 Mar;73(3):1532-42. doi: 10.1128/IAI.73.3.1532-1542.2005. Infect Immun. 2005. PMID: 15731051 Free PMC article.
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J. Sing A, et al. J Exp Med. 2002 Oct 21;196(8):1017-24. doi: 10.1084/jem.20020908. J Exp Med. 2002. PMID: 12391013 Free PMC article.

Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages - PubMed (original) (raw)